DCT and neoplasm: To determine whether the MCMV-TRP2-induced anti-tumor immunity is FcγR dependent, WT mice and mice deficient in all four FcγRs were vaccinated with MCMV-TRP2, and two weeks later challenged with B16 tumor cells.